These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
692 related articles for article (PubMed ID: 30393090)
1. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Nicolatou-Galitis O; Schiødt M; Mendes RA; Ripamonti C; Hope S; Drudge-Coates L; Niepel D; Van den Wyngaert T Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Feb; 127(2):117-135. PubMed ID: 30393090 [TBL] [Abstract][Full Text] [Related]
2. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)]. Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441 [TBL] [Abstract][Full Text] [Related]
3. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases. Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439 [TBL] [Abstract][Full Text] [Related]
4. Management of Medication-Related Osteonecrosis of the Jaw. Williams WB; O'Ryan F Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):517-25. PubMed ID: 26515735 [TBL] [Abstract][Full Text] [Related]
5. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors. Dodson TB Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367 [TBL] [Abstract][Full Text] [Related]
6. Denosumab-related osteonecrosis of the jaw: a report of 2 cases and review of the literature. Chehal H; Nikitakis NG; Islam MN; Goodchild JH; Mordini L; Bhattacharyya I Gen Dent; 2019; 67(1):42-46. PubMed ID: 30644830 [TBL] [Abstract][Full Text] [Related]
7. Update MRONJ and perspectives of its treatment. Voss PJ; Poxleitner P; Schmelzeisen R; Stricker A; Semper-Hogg W J Stomatol Oral Maxillofac Surg; 2017 Sep; 118(4):232-235. PubMed ID: 28697987 [TBL] [Abstract][Full Text] [Related]
8. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis. Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808 [TBL] [Abstract][Full Text] [Related]
9. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor? Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523 [TBL] [Abstract][Full Text] [Related]
10. Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study. Kajizono M; Sada H; Sugiura Y; Soga Y; Kitamura Y; Matsuoka J; Sendo T Biol Pharm Bull; 2015; 38(12):1850-5. PubMed ID: 26632176 [TBL] [Abstract][Full Text] [Related]
11. Treatment of Medication-Related Osteonecrosis of the Jaw: Controversies in Causality and Therapy. Halpern LR; Adams DR Dent Clin North Am; 2024 Jan; 68(1):67-85. PubMed ID: 37951638 [TBL] [Abstract][Full Text] [Related]
12. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management]. Dupic G; Collangettes D; Dillies AF; Calvet L; Tournilhac O; Bay JO; Mahammedi H Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453 [TBL] [Abstract][Full Text] [Related]
13. A real-world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab. Bracchi P; Zecca E; Brunelli C; Miceli R; Tinè G; Maniezzo M; Lo Dico S; Caputo M; Shkodra M; Caraceni AT Cancer Med; 2023 Sep; 12(17):18317-18326. PubMed ID: 37559413 [TBL] [Abstract][Full Text] [Related]
14. Medication-related osteonecrosis of the jaw: knowledge and perceptions of medical professionals on the usage of bone modifying agents and dental referrals. Acharya S; Patil V; Ravindranath V; Kudva A; Nikhil K J Med Life; 2022 Mar; 15(3):368-373. PubMed ID: 35449990 [TBL] [Abstract][Full Text] [Related]
15. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I. Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591 [TBL] [Abstract][Full Text] [Related]
16. Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: A case report. Diniz-Freitas M; Fernández-Feijoo J; Diz Dios P; Pousa X; Limeres J J Clin Periodontol; 2018 May; 45(5):570-577. PubMed ID: 29479739 [TBL] [Abstract][Full Text] [Related]
17. The Prevention of Medication-related Osteonecrosis of the Jaw. Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916 [TBL] [Abstract][Full Text] [Related]
18. Preventing, identifying, and managing medication-related osteonecrosis of the jaw: a practical guide for nurses and other allied healthcare professionals. Drudge-Coates L; Van den Wyngaert T; Schiødt M; van Muilekom HAM; Demonty G; Otto S Support Care Cancer; 2020 Sep; 28(9):4019-4029. PubMed ID: 32307659 [TBL] [Abstract][Full Text] [Related]
19. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. Kawahara M; Kuroshima S; Sawase T Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769 [TBL] [Abstract][Full Text] [Related]
20. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone. Shibahara T Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]